Filtering by:
Lung CancerFDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
How to Test Your Home for Radon
Getting your home tested for radon can help protect you and your family from a key cause of lung cancer.
Who Should Be Screened for Lung Cancer?
A harsh truth about lung cancer is that it doesn’t usually cause symptoms until the cancer is already advanced and not able to be cured. That’s why the idea of screening – looking for lung cancer in people who do not have any symptoms – is appealing.
Lung Cancer Risks for Non-smokers
30,000 Americans are expected to die of lung cancer this year – without ever having lit a cigarette and smoked. Here’s what we know about why some non-smokers get lung cancer.
Lung Cancer Survivor Makes Wish For Peace
Back when lung cancer survivor Wendy Ryals still had a house and a job, she dreamed of someday saving enough money to help the homeless. But then she became homeless herself.
FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer
The US Food and Drug Administration had approved the immunotherapy drug Opdivo (nivolumab) to treat people with small cell lung cancer (SCLC).
Lung Cancer Rates in Young Women Now Higher Than in Young Men
Researchers from the American Cancer Society and the National Cancer Institute have found rates of lung cancer are higher in women than men among white and Hispanic people born since 1965.
Annual Report to the Nation: Cancer Death Rates Continue Long Decline
The death rate from cancer in the United States is continuing to fall among men, women, and children, according to the latest Annual Report to the Nation on the Status of Cancer.
